X

Vous n'êtes pas connecté

Articles similaires

Sorry! Image not available at this time

New accommodation service given the green light after six years of waiting

nynganobserver.com.au - 27/Jun 02:00

Council approved a development application six years ago.

Sorry! Image not available at this time

Environmental Lights Announces the Launch of Cove Wash – Dual Bend LED Lighting Products

constructionlinks.ca - 27/Jun 21:03

Cove Wash 4-in-1 PixelControl – Dual Bend Cove Wash – Dual Bend – Monochrome New high-output cove lighting products bend around corners and...

Sorry! Image not available at this time

Newsdeck: US FDA approves Lilly’s Alzheimer’s drug

daily maverick - 02/Jul 19:01

July 2 - The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly's LLY.N donanemab for patients with early Alzheimer's,...

Jet2 announces new route between the UK and the ‘coast of light’ in southern Spain

theolivepress.es - 27/Jun 11:00

BRITISH tourists may be about to discover Spain’s largely unheralded ‘coast of light’ as Jet2 announces a raft of new flights to the region. The...

Sorry! Image not available at this time

FDA Approves Ohtuvayre (ensifentrine) for the Maintenance Treatment of Chronic Obstructive Pulmonary Disease (COPD)

drugs.com - 26/Jun 21:06

LONDON and RALEIGH, N.C., June 26, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the...

Sorry! Image not available at this time

FDA Approves New Drug to Treat Alzheimer's, Kisunla

drugs.com - 02/Jul 19:07

TUESDAY, July 2, 2024 -- A new drug to treat Alzheimer's disease was approved by the U.S. Food and Drug Administration on Tuesday. In clinical trials,...

Sorry! Image not available at this time

FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder

zacks.com - 24/Jun 14:19

Per argenx (ARGX), the label expansion to Vyvgart Hytrulo makes it the first FDA-approved medication with a novel mechanism of action to treat chronic...

Sorry! Image not available at this time

Epkinly (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

drugs.com - 27/Jun 04:06

COPENHAGEN, Denmark; June 27, 2024 – Genmab A/S (Nasdaq: GMAB) today announced that the U.S. Food and Drug Administration (FDA) has approved...